Clinical Trial Update: Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SB-509 in diabetic neuropathy has completed enrollment and status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• SB-509

Snippet

Sponsor: Sangamo Therapeutics | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED